Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect. Biopharma has played a starring role during the COVID-19 pandemic, developing and distributing vaccines in record time. Still, the industry is way behind the curve in adopting new technologies that will make its supply chain more efficient and […]

Long COVID, or long-haulers syndrome, is a puzzling range of lingering symptoms and complications after COVID-19 infection. Last week, the U.S. Centers for Disease Control and Prevention (CDC) issued new guidance for long COVID, loosely defined as illness at least four weeks after acute infection. The guidance notes that primary care physicians can typically handle post-COVID conditions, but […]

Newly-formed 180 Life Sciences is seeking to leverage existing antibodies for TNF-related inflammatory and fibrotic indications including Dupuytren’s contracture, frozen shoulder, post-operative cognitive decline, and NASH. Back in the late 1980s, a group of researchers led by Professor Sir Marc Feldmann, Ph.D., demonstrated that rheumatoid arthritis-diseased joints are riddled with pro-inflammatory cytokines, one of them […]